NCT07461051

Brief Summary

The study was conducted as a randomized controlled trial to evaluate the effects of foot bath application on symptom severity, quality of life, and pain levels in women with premenstrual syndrome. The research was carried out with 92 midwifery students. While foot bath therapy was applied to the experimental group, no intervention was performed in the control group. Data were collected through face-to-face interviews using the Personal Information Form, Premenstrual Symptom Scale, Visual Analog Scale, and SF-36 Quality of Life Scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 13, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

March 10, 2026

Completed
Last Updated

April 22, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

February 13, 2026

Last Update Submit

April 18, 2026

Conditions

Keywords

Foot bathPremenstrual SyndromeQuality of lifepain

Outcome Measures

Primary Outcomes (4)

  • Personal Information Form

    The Personal Information Form was developed by the researchers to determine the participants' sociodemographic and menstrual characteristics.

    Pretest assessments were administered to all participants in both groups before the intervention.

  • Premenstrual Syndrome Scale (PMSS)

    The Premenstrual Syndrome Scale (PMSS) was developed by Gençdoğan (2006) based on DSM-III and DSM-IV-TR diagnostic criteria to assess the severity of premenstrual symptoms. The scale consists of 44 items and is structured as a 5-point Likert-type instrument. Each item is rated between "Never" (1 point) and "Always" (5 points), and higher total scores indicate greater symptom severity. The scale includes nine subdimensions: depressive mood, anxiety, fatigue, irritability, depressive thoughts, pain, appetite changes, sleep changes, and bloating.

    * "Baseline 1" * "3 months later" * "4 weeks later" * "approximately 4months"

  • Visual Analog Scale (VAS)

    The Visual Analog Scale (VAS) is a one-dimensional measurement tool used to assess pain intensity and was first developed by Hayes and Patterson (1921). The scale consists of a 10-cm (100 mm) horizontal or vertical line anchored by "No pain" at one end and "Unbearable pain" at the other. Participants are asked to mark the point that best represents their perceived pain intensity. The VAS is widely accepted as a reliable and sensitive tool for measuring pain severity in clinical research (Ahearn, 1997).

    * "Baseline 1" * "3 months later" * "4 weeks later" * "Approximately 4months"

  • SF-36 Short Form

    The SF-36 is a 36-item self-report instrument developed to evaluate health-related quality of life. The scale measures eight domains: physical functioning, role limitations due to physical problems, bodily pain, general health perception, energy/fatigue, social functioning, role limitations due to emotional problems, and mental well-being. Scores are calculated according to standardized scoring procedures, with higher scores indicating better quality of life. The Turkish validity and reliability of the scale were established by Demiral et al. (2006).

    * "Baseline 1" * "3 months later" * "4 weeks later" * "Approximately 4months"

Study Arms (2)

Experimental: Group 1 Foot bath therapy

EXPERIMENTAL

Foot bath therapy

Other: Foot bath therapy

Group 2

NO INTERVENTION

Interventions

Foot bath therapy was applied during the luteal phase of three menstrual cycles.

Experimental: Group 1 Foot bath therapy

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with premenstrual syndrome (PMS)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • and 25 years of age
  • Having no chronic disease
  • Having a symptom severity score of 5 or higher according to the VAS,
  • Voluntarily agreeing to participate in the study.

You may not qualify if:

  • Psychiatric disorder
  • Secondary dysmenorrhea.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İnonü Universty

Ağrı, Ağrı, 04100, Turkey (Türkiye)

Location

Related Publications (3)

  • Demiral, Y., Ergor, G., Unal, B., Semin, S., Akvardar, Y., Kivircik, B., & Alper, Z. (2006). Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health, 6, 247. https://doi.org/10.1186/1471-2458-6-247

    RESULT
  • Ahearn, E. P. (1997). The use of visual analog scales in mood disorders: A critical review. Journal of Psychiatric Research, 31(5), 569-579.

    RESULT
  • Gençdoğan, B. (2006). Development of a scale for measuring premenstrual syndrome symptoms. Turkish Psychological Counseling and Guidance Journal, 3(26), 51-58.

    RESULT

MeSH Terms

Conditions

Premenstrual SyndromePain

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study was conducted using a randomized controlled pretest-posttest experimental design with a follow-up assessment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asistant Professor

Study Record Dates

First Submitted

February 13, 2026

First Posted

March 10, 2026

Study Start

August 1, 2024

Primary Completion

April 1, 2025

Study Completion

June 1, 2025

Last Updated

April 22, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

we don't share individual participant data with other researchers

Locations